F8 and hemophilia: Trial density was moderately correlated with FVIII and FIX usage (r = 0.436; P < .001) and physician density (r = 0.417; P = .001) and weakly correlated with the expected number of men with hemophilia and the amount a country spent on health care as a percentage of the GDP (Table 2).